XAIR MEXC RealStocks
Own real XAIR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 16:46:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Beyond Air, Inc. (XAIR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.06, with a market capitalization of $2.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.85 to $53.20. This page covers its latest market performance, valuation, price trends and company information.
$2.10M | |
$2.04 | |
$2.12 | |
$1.98 | |
$2.13 | |
24.42K | |
232.18K | |
-- | |
$53.20 | |
$1.85 | |
-- | |
-- |
Beyond Air, Inc. (XAIR) is currently trading at $2.06 as of 2026-11-16 16:45:00, down 6.10% ($0.13) from the previous close of $2.13
During today's regular trading session, XAIR has traded between $1.98 and $2.12, with a trading volume of 24.42K shares. The current price is near the middle of today's range.
Over the past seven days, Beyond Air, Inc. (XAIR) moved from $2.18 to $2.06, representing a decline of 5.50% ($0.12).
The stock traded between $1.85 and $3.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 149.25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.4%
XAIR is currently trading at $2.06, placing it 0.4% of the way from its 52-week low of $1.85 to its 52-week high of $53.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 54 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Beyond Air, Inc. (XAIR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to XAIR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between XAIR shares and USD.
XAIR Shares to USD
1.00 XAIR shares = 2.06 USD
Calculations are estimates based on the latest available price and are for reference only.